×
About 72,195 results

ALLMedicine™ Anemia Center

Research & Reviews  21,520 results

Secondary Thrombocytosis
https://emedicine.medscape.com/article/206811-overview

Aug 10th, 2022 - Practice Essentials Platelets are acute-phase reactants; therefore, platelet counts increase in response to various stimuli, including systemic infections, inflammatory conditions, bleeding, and tumors. [1, 2, 3] This phenomenon is called reactive...

The association of soluble Klotho levels with anemia and hemoglobin variability in hemo...
https://doi.org/10.1111/sdi.13122
Seminars in Dialysis; Topal M, Guney I

Aug 10th, 2022 - The anti-aging protein Klotho levels are decreased, and Klotho deficiency is associated with cardiovascular diseases in patients with chronic kidney disease. There are recent studies about the relation between soluble Klotho levels and anemia. We ...

Red cell distribution width, anemia, and lower-extremity physical function among rural-...
https://doi.org/10.1007/s40520-022-02187-9
Aging Clinical and Experimental Research; Jiang Z, Han X et. al.

Aug 10th, 2022 - Elevated red cell distribution width (RDW) has been associated with degenerative conditions in aging. We aimed to evaluate the associations of RDW and anemia with lower-extremity physical function among rural-dwelling older adults. This population...

Secondary Thrombocytosis
http://emedicine.medscape.com/article/206811-overview

Aug 10th, 2022 - Practice Essentials Platelets are acute-phase reactants; therefore, platelet counts increase in response to various stimuli, including systemic infections, inflammatory conditions, bleeding, and tumors. [1, 2, 3] This phenomenon is called reactive...

Secondary Thrombocytosis Treatment & Management
https://emedicine.medscape.com/article/206811-treatment

Aug 10th, 2022 - Medical Care The primary treatment of secondary thrombocytosis (reactive thrombocytosis) should address the underlying cause of the thrombocytosis. For example, iron supplementation may normalize platelet counts in patients with thrombocytosis sec...

see more →

Guidelines  26 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH...
https://doi.org/10.1200/JCO.18.02142
Journal of Clinical Oncology : Official Journal of the Am... Bohlius J, Bohlke K et. al.

Apr 11th, 2019 - To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. PubMed and the Cochrane Library were searched for randomiz...

see more →

Drugs  925 results see all →

Clinicaltrials.gov  2,775 results

Iron Supplement to Improve Iron Status Following Bariatric Surgery
https://clinicaltrials.gov/ct2/show/NCT02404012

Aug 5th, 2022 - Objectives: To determine the most effective oral iron supplementation regimen for repletion of iron deficiency in patients who have had gastric bypass or sleeve gastrectomy. In iron deficient patients, two supplement regimens will be compared: Fer...

Improving White Blood Cell Collection From Healthy Donors
https://clinicaltrials.gov/ct2/show/NCT01553214

Aug 5th, 2022 - Bacterial and fungal infections in neutropenic patients or in patients with inherited disorders of neutrophil function continue to cause substantial morbidity and mortality. In particular, fungal infections are an increasingly important cause of d...

Iron Supplementation for Geriatric Hip Fractures
https://clinicaltrials.gov/ct2/show/NCT05489952

Aug 5th, 2022 - Geriatric hip fracture is an important disease that affects the health life of the elderly in China. Geriatric hip fracture is often complicated by a variety of comorbidities due to advanced age. And anemia is a common comorbidity. At present peri...

A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
https://clinicaltrials.gov/ct2/show/NCT05490446

Aug 5th, 2022 - This purpose of this study is to establish proof of concept of AG-946 in participants with LR-MDS in Phase 2a and to compare the effect of AG-946 versus placebo and to detect a dose response for erythroid response in participants with LR-MDS in Ph...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Aug 5th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

see more →

News  3,534 results

Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in Veterans
https://www.mdedge.com/fedprac/avaho/article/256893/multiple-myeloma/agent-orange-exposure-transformation-mgus-multiple
Jyothi Dodlapati, MD, James A. Hall, DO et. al.

Aug 9th, 2022 - Multiple myeloma (MM) accounts for 1% to 2% of all cancers and slightly more than 17% of hematologic malignancies in the United States. 1 MM is characterized by the neoplastic proliferation of immunoglobulin (Ig)-producing plasma cells with ≥ 10% c.

CV Admissions on the Rise in Americans With Cancer
https://www.medscape.com/viewarticle/978761

Aug 5th, 2022 - Although cardiovascular disease (CVD) is known to often strike the mortal blow in patients with cancer, a national analysis puts in stark relief the burden of CV-related hospitalizations in this vulnerable population. Results show that between 200...

A Special Supplement on Hot Topics in Primary Care 2022
https://www.mdedge.com/familymedicine/article/254496/special-supplement-hot-topics-primary-care-2022
MDedge Family Medicine;

Jul 25th, 2022 - Hot Topics in Primary Care 2022 is a resource that explores the newest developments in primary care topics that impact your daily clinical practice. Click on the link below to access the entire supplement.

Can early introduction of gluten reduce risk of celiac disease?
https://www.mdedge.com/familymedicine/article/256409/gastroenterology
MDedge Family Medicine; Ashley U. Hall, MD, FACOG, Erica S. Meisenheimer, MD, MBA, FAAFP et. al.

Jul 20th, 2022 - ILLUSTRATIVE CASE You are seeing a 2-month-old female infant for a routine well-child visit. The birth history was unremarkable.

Essential strategies and tactics for managing sickle cell disease
https://www.mdedge.com/familymedicine/article/256319/hematology/essential-strategies-and-tactics-managing-sickle-cell
MDedge Family Medicine; Robert Allen Perkins, MD, MPH, Ann Payne- Johnson, MD et. al.

Jul 18th, 2022 - The group of disorders known as sickle cell disease (SCD) is one of the more common genetic hemoglobinopathies. Homozygous production of the S variant of hemoglobin (Hb) in red blood cells (RBCs) results in profound sickling under conditions of ph.

see more →

Patient Education  98 results see all →